home / stock / ptgx / ptgx short
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,611,924 |
Total Actual Volume | 21,616,594 |
Short Trends | |
---|---|
Cover Days | 6 |
Short Days | 8 |
No Change Days | 6 |
Averages | |
---|---|
Average Short Volume | 80,596 |
Average Short Percentage | 46.03% |
Is there a PTGX Short Squeeze or Breakout about to happen?
See the PTGX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Stock Date | Open Price | Close Price | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
2022-06-30 | 8.01 | 7.91 | 8.065 | 7.76 | 952,450 | 80,460 | 65.0613 |
2022-06-29 | 8.36 | 8.07 | 8.7 | 8 | 2,171,568 | 124,599 | 9.4852 |
2022-06-28 | 9.18 | 8.45 | 9.3 | 8.3 | 818,381 | 106,218 | 86.5270 |
2022-06-27 | 9.07 | 9.12 | 9.29 | 8.91 | 702,598 | 85,208 | 64.7443 |
2022-06-24 | 9.35 | 9.08 | 9.43 | 8.57 | 2,056,775 | 83,741 | 49.9538 |
2022-06-23 | 8.3 | 9.3 | 9.32 | 8.24 | 1,108,189 | 63,352 | 63.0971 |
2022-06-22 | 8.02 | 8.28 | 8.6 | 7.92 | 928,550 | 41,695 | 45.8868 |
2022-06-21 | 8 | 8.19 | 8.53 | 8 | 1,107,371 | 60,481 | 43.8548 |
2022-06-16 | 7.15 | 7.4 | 7.45 | 7.1 | 1,190,329 | 94,788 | 43.4301 |
2022-06-15 | 7.39 | 7.48 | 7.72 | 7.27 | 918,305 | 62,698 | 31.1625 |
2022-06-14 | 7.06 | 7.34 | 7.41 | 6.91 | 1,283,991 | 70,177 | 10.7333 |
2022-06-13 | 7.18 | 7.06 | 7.28 | 6.93 | 1,370,487 | 121,229 | 53.1159 |
2022-06-09 | 8.86 | 7.89 | 9.13 | 7.88 | 1,471,998 | 194,894 | 52.3037 |
2022-06-08 | 9.11 | 8.98 | 9.46 | 8.93 | 651,067 | 84,074 | 60.6787 |
2022-06-06 | 9.15 | 8.88 | 9.51 | 8.79 | 697,932 | 60,538 | 61.1180 |
2022-06-03 | 8.82 | 9.2 | 9.21 | 8.67 | 742,114 | 78,476 | 46.6869 |
2022-06-02 | 8.54 | 8.99 | 9.01 | 8.41 | 591,975 | 51,563 | 45.7906 |
2022-06-01 | 8.85 | 8.53 | 8.95 | 8.315 | 913,239 | 44,440 | 29.3297 |
2022-05-31 | 8.85 | 8.76 | 8.975 | 8.6 | 1,077,532 | 55,726 | 32.8825 |
2022-05-26 | 7.9 | 8.31 | 8.4 | 7.62 | 861,743 | 47,567 | 24.8498 |
Protagonist Therapeutics Inc. Company Name:
PTGX Stock Symbol:
NASDAQ Market:
Protagonist Therapeutics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
Protagonist Therapeutics to Participate at the Jefferies Healthcare Conference PR Newswire NEWARK, Calif. , June 1, 2022 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq: PTGX) ("Protagonist" or "the Company") today announced that Dinesh V. Pat...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech stocks have never really managed to recreate the success they had in 2020 amid the Covid-19 outbreak. For a second year in running, the sector is caught in a rut, underperforming the beaten-down broader market. Th...
Protagonist Therapeutics to Present Updated Phase 2 Rusfertide Clinical Results in Polycythemia Vera (PV) at ASCO 2022 PR Newswire Enrollment completed and dosing resumed in the ongoing Phase 2 REVIVE study Resumption of rusfertide administration after suspensi...